Anti-viral Action Against Type 1 Diabetes Autoimmunity

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,252

Participants

Timeline

Start Date

May 8, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2027

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Comirnaty Injectable Product

Vaccination

DRUG

Sodium Chloride 0.9% Inj

Vaccination

Trial Locations (9)

1090

NOT_YET_RECRUITING

Medical University of Vienna, Dept. of Pediatric and Adolescent Medicine, Waehringer Gürtel 18-20, 1090 Vienna, Austria, Vienna

3000

RECRUITING

University Hospitals Leuven, Faculty of Medicine, Catholic University of Leuven, Leuven

20213

RECRUITING

Lund University Dep. of Clinical Sciences Malmo, Skane University Hospital SUS, Malmo

30173

RECRUITING

AUF DER BULT, Kinder- und Jugendkrankenhaus, Hanover

80939

RECRUITING

Klinikum rechts der Isar of Technical University Munich and Institute for Diabetes Research, Helmholtz Munich, Munich

01307

RECRUITING

Klinik und Poliklinik f. Kinder und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden

Unknown

NOT_YET_RECRUITING

Birmingham Women's and Children's NHS Foundation Trust, Birmingham

NOT_YET_RECRUITING

Cambridge University Hospitals NHS Foundation Trust, Cambridge

RECRUITING

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle

All Listed Sponsors
collaborator

Helmholtz Zentrum München

INDUSTRY

collaborator

University Hospital Carl Gustav Carus

OTHER

collaborator

Kinderkrankenhaus auf der Bult

OTHER

collaborator

Skane University Hospital

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

collaborator

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

Birmingham Women's and Children's NHS Foundation Trust

OTHER

lead

Technical University of Munich

OTHER